Urology Subspecialty News
- Obesity measures linked to higher prevalence of benign prostatic enlargement, evidence quality very low Meta-analysis · Eur Urol · 2026-11-18
A meta-analysis of 24 mostly cross-sectional studies found waist circumference over 90 cm and higher BMI associated with prevalent benign prostatic enlargement and moderate-to-severe LUTS, particularly in Asian men, with very low certainty of evidence.
Why it matters: Adds support for a possible link between adiposity and LUTS/BPE, though cross-sectional design limits causal inference.
- Phase 3 trial registered testing berobenatide for stress incontinence in women with obesity Trial registered · ClinicalTrials.gov · 2026-11-12
A planned 900-participant, roughly 63-week trial will evaluate the safety and effectiveness of berobenatide in women with stress urinary incontinence who also have obesity or overweight. Registered on ClinicalTrials.gov and not yet recruiting; estimated start 2026-11-17; planned enrollment 900.
Why it matters: A positive trial could add a pharmacologic option for SUI in a population where weight is a known risk factor and surgical candidacy may be limited.
- No significant volume-outcome link for AMS 800 sphincter after adjustment in European registry Prospective · Eur Urol Focus · 2026-11-18
Among 684 patients in the prospective SATURN registry, crude 1-year revision and complication rates varied by center volume, but no statistically significant association remained after multivariable adjustment for patient and procedure factors.
Why it matters: Suggests center volume alone may not explain AMS 800 outcome variation once case mix is accounted for.
- Longer oral mucosa grafts for urethroplasty linked to more donor-site morbidity Retrospective · World J Urol · 2026-11-15
Among 304 patients who underwent oral mucosa graft urethroplasty (115 with strictures ≤5 cm, 189 with strictures >5 cm), 21.1% reported at least one significant oral complication on follow-up questionnaires (up to 12 years). Oral numbness occurred in 17.1% overall, more often in the longer-stricture group (20.1% vs 12.2%), and discomfort while smiling or laughing was significantly more frequent in that group (7.4% vs 0.9%, p=0.01), with trends toward more pain, trismus, and eating difficulty that did not all reach statistical significance.
Why it matters: These findings support surgical planning that minimizes graft length and favors buccal-only harvest sites when feasible to limit long-term donor-site symptoms.
- Pump-preserving AUS revision feasible when pump is functioning normally Prospective · Urology · 2026-11-09
In a prospective single-center series of 60 artificial urinary sphincter revisions, surgeons preserved a normally functioning pump in all cases, with no pump-related complications and earlier device reactivation (2 weeks vs standard 6 weeks).
Why it matters: Suggests pump preservation may be a feasible option in selected AUS revisions to limit scrotal dissection and shorten reactivation time.
- Allium covered stents beat Memokath for radiation ureteral strictures but carry unique fistula risk Retrospective · World J Urol · 2026-11-09
Among 149 patients (205 ureteral units) treated for radiation-induced ureteral strictures, Allium stents showed higher 12- and 36-month primary success (75.9% vs 49.3% and 33.2% vs 23.2%) and cumulative success (96.3% vs 91.5% at 12 months, 64.0% vs 28.2% at 36 months) compared with Memokath stents, with median primary success duration of 30 vs 12 months (log-rank P < 0.001); ureteral fistulas occurred in 11 patients, exclusively in the Allium group.
Why it matters: For refractory radiation strictures, covered self-expandable stents may offer meaningfully longer patency than thermo-expandable stents, though the fistula signal tied to larger caliber and tandem stenting warrants careful sizing and patient selection.
- Meta-analysis: urethroplasty for post-BPH surgery bulbomembranous strictures shows 90% pooled patency Meta-analysis · BJU Int · 2026-11-01
A systematic review and meta-analysis of 417 patients from 9 observational studies found an overall pooled patency rate of 90% for urethroplasty after bulbomembranous strictures following BPH surgery, with patency around 87-94% depending on technique, though definitions of patency and continence varied widely.
Why it matters: Provides pooled benchmark patency rates for a challenging post-BPH stricture population, though heterogeneous outcome definitions and moderate-to-serious risk of bias limit certainty.
- Retrospective series reports outcomes after revision of difficult-to-catheterize continent channels Retrospective · Neurourol Urodyn · 2026-10-29
In a single-institution retrospective review of 45 adults undergoing 54 continent catheterizable channel revisions, 76% were free from reoperation at median 46-month follow-up, with success rates similar across suprafascial, subfascial, and replacement techniques.
Why it matters: Is hypothesis generating for channel revision technique selection given single-center retrospective design without randomized comparison.
- AUA/SMSNA update ejaculation disorders guideline with new statements on PDE5i, clomipramine, HA injection Guideline · J Urol · 2026-11-18
The amended AUA/SMSNA Disorders of Ejaculation guideline adds an expert opinion statement on PDE5 inhibitors for premature ejaculation and new statements supporting daily or on-demand clomipramine and glans hyaluronic acid injection, with caveats.
Why it matters: Updates evidence-based options clinicians can discuss with patients for premature ejaculation, emphasizing shared decision-making.
- Eur Urol review updates classification systems and evidence gaps in male infertility Review · Eur Urol · 2026-11-13
A narrative review in European Urology summarizes new pathophysiological, endocrine (APHRODITE), and phenotypic classification systems for male factor infertility and highlights limited evidence for several add-on diagnostics and empirical therapies.
Why it matters: Offers urologists a current framework for classifying and evaluating male infertility beyond standard semen analysis.
- Company recalls supplement capsules with hidden sildenafil and acetaminophen FDA action · FDA · 2026-11-12
Game Changer Products LLC issued a voluntary nationwide recall of 10 Day Forecast Capsules after testing found undeclared sildenafil and acetaminophen, posing risks for patients on nitrates or with liver disease.
Why it matters: Patients using unregulated sexual-enhancement supplements may be unknowingly exposed to PDE5 inhibitors with drug interaction risks.
- Mail-in semen analysis kits show 93% completion within 16 weeks Prospective · J Urol · 2026-11-12
Among 35,444 patients using a national mail-in semen analysis platform, 93% completed testing within 16 weeks, with no meaningful differences by urbanization or neighborhood deprivation, though nearly a third tested before meeting guideline duration-of-infertility criteria.
Why it matters: Suggests mail-in semen analysis may reduce geographic and logistical barriers to male fertility evaluation.
- Volumetric ratio may help select children for robotic nephrectomy in Wilms tumor Prospective · Eur Urol Oncol · 2026-11-08
In a prospective single-center series of 60 radical nephrectomies for presumptive Wilms tumor, about 40% (23/60) of children were selected for robot-assisted surgery using a new tumor-to-blood-volume ratio, with no significant difference in oncologic outcomes versus open surgery.
Why it matters: Suggests a volumetric selection criterion could help identify children suitable for robotic nephrectomy in Wilms tumor, pending external validation in larger cohorts.
- Review outlines when genetic testing is useful in CAKUT for urologists Review · Eur Urol Focus · 2026-11-08
A review discusses when genetic evaluation adds value in congenital anomalies of the kidney and urinary tract, emphasizing bilateral or severe anomalies, syndromic features, familial disease, and anatomy-function mismatch, while noting genetics should not drive surgical decisions alone.
- First multicentre study of Versius robot in pediatric urology reports interim safety data Prospective · J Pediatr Urol · 2026-11-06
In 60 procedures (mostly pyeloplasty) across three UK centres, 98.3% were completed robotically with one open conversion and no transfusions; median operative time was 195.5 minutes.
Why it matters: Early prospective data suggest the Versius platform may be feasible for pediatric minimally invasive urology, pending larger follow-up.
- Low-level pyuria tied to large jump in antibiotic prescribing for suspected pediatric UTI Retrospective · Pediatrics · 2026-11-06
Among 1150 pediatric ambulatory visits with urinalysis, 191 (16.6%) patients received antibiotics, and trace-to-low pyuria was associated with empiric antibiotic initiation (adjusted OR 6.62, 95% CI 3.72-11.79) versus no pyuria. This level of pyuria accounted for an adjusted attributable fraction of 17.0% (95% CI 10.3%-23.2%) for overtreatment in culture-negative children, compared with only 1.8% (95% CI 1.1%-2.4%) attributable fraction for treatment of culture-confirmed UTI.
Why it matters: Suggests that weighing degree of pyuria alongside age, symptoms, and risk factors rather than treating any pyuria as definitive could help reduce unnecessary antibiotic exposure in children evaluated for UTI.
- Thermocautery circumcision linked to far fewer early complications than bipolar sleeve or scalpel Retrospective · J Pediatr Urol · 2026-11-06
In a frequency-matched retrospective cohort of 31,100 boys, thermocautery guillotine circumcision had a complication rate of 0.6% versus 8.68% (bipolar sleeve) and 7.21% (scalpel guillotine), with zero bleeding events requiring suture ligation versus 15 and 25 respectively.
Why it matters: Raises the question of whether thermocautery technique reduces early circumcision complications, though retrospective design and single-center practice patterns limit causal inference.
- Nearly half of retractile testes ascend or need orchiopexy by age 7 in cohort study Prospective · J Urol · 2026-11-04
In a prospective single-institution cohort of 237 boys with retractile testicle(s) followed to median 7 years, cumulative incidence of testicular ascent was 47% and of orchiopexy was 57% by 84 months, with lower BMI and right-sided laterality associated with ascent.
Why it matters: Suggests boys with retractile testes warrant longer-term surveillance by a pediatric urologist rather than single-visit reassurance.
- New expert consensus aims to standardize surgery for pediatric kidney cancer Guideline · citybuzz - · 2026-11-03
A new expert consensus statement seeks to standardize surgical approach for childhood kidney cancer, according to the report.
Why it matters: A consensus statement may help reduce variability in surgical management of pediatric renal tumors.
- Multidisciplinary review addresses undescended testis management in medically complex children Review · J Urol · 2026-10-29
A narrative review by specialists across anesthesia, genetics, oncology, and urology examines how standard orchiopexy timing recommendations for undescended testis may need individualized reconsideration in children with syndromic or developmental conditions given elevated surgical risk.
Why it matters: Offers a framework for weighing surgical and anesthetic risk against fertility and oncologic benefit when managing undescended testis in medically complex children.
- FDA device-report analysis flags higher serious injury and death rates for histotripsy vs thermal ablation Retrospective · Radiology · 2026-11-18
Analysis of FDA MAUDE reports found higher rates of serious injury (86% vs 20%) and death (14% vs 2%) among histotripsy adverse event reports compared with microwave/radiofrequency ablation over comparable 24-month postmarket periods.
Why it matters: Raises safety questions about early postmarket histotripsy use that warrant prospective evaluation; MAUDE reporting is passive and not denominator-adjusted.
- Phase 2 trial registered testing paclitaxel prostate implant for BPH-related LUTS Trial registered · ClinicalTrials.gov · 2026-11-10
A randomized, double-blind, placebo-controlled phase 2 trial will evaluate RT-310, a paclitaxel prostate implant, for lower urinary tract symptoms due to BPH in about 86 patients. Registered on ClinicalTrials.gov and not yet recruiting; estimated start 2027-01; planned enrollment 86.
- Dual-LLM consensus abstraction far more accurate than human abstraction in prostate registry Study · J Urol · 2026-11-12
In 3,210 pathology and 4,739 MRI reports from the Mayo Clinic Prostate Cancer Registry, consensus abstraction using two LLMs achieved median error rates of 0.09% (pathology) and 0.17% (MRI), compared with 2.81% and 1.01% for human abstractors; individual LLMs alone had error rates of 0.27-1.02%. Abstracting all 136,510 data elements took an estimated 32 hours with the LLM pipeline versus 952 hours for human abstraction.
Why it matters: A dual-LLM consensus architecture may substantially cut abstraction time and errors for large clinical registries, supporting consideration for integration into prospectively maintained databases.
- New consensus statements issued on minimally invasive BPH surgical treatments Guideline · UroToday · 2026-11-09
A consensus panel issued statements on the role and application of minimally invasive surgical treatments for male LUTS due to benign prostatic enlargement and obstruction.
Why it matters: Offers practical consensus guidance for selecting among MIST options in BPH/LUTS management.
- Stone-related ED visits before surgery vary by modality, race, and neighborhood vulnerability Retrospective · Urology · 2026-11-09
In an analysis of over 1 million patients from an EHR network, acute stone-related healthcare utilization in the year before definitive surgery was higher before PCNL and lower before SWL versus ureteroscopy, and increased with Black race and higher social vulnerability index, but not rurality.
Why it matters: Raises the question of whether access barriers contribute to acute presentations before definitive stone surgery, warranting prospective evaluation.
Urology clinical trials · Urology podcasts · Urology videos · Meetings · Daily edition archive
Loading today's edition…